BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014

Jun 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-06-03

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-03	Common Stock	S	1000	$59.8762	Disposed	179257	Direct
2014-06-04	Common Stock	S	1000	$62.5205	Disposed	178257	Direct
2014-06-04	Common Stock	A	50900	—	Acquired	229157	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-04	Stock Option (right to buy) Common Stock	$63.10	A	191000	Acquired	2024-06-03	Common Stock (191000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	46195	Indirect

Footnotes

F1: The reporting person and his spouse act as trustees for the Bienaime Family Trust.

F2: The price in column 4 is a weighted average price. The price actually received ranged from $59.86 to $59.878. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: The price in column 4 is a weighted average price. The price actually received ranged from $61.55 to $62.91. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F4: Restricted stock units granted on June 4, 2014. Price not applicable.

F5: Option grant vests 6/48ths on December 4, 2014, and 1/48th on the 4th day of every month thereafter.